We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$24.1B
AUM Growth
-$134M
Cap. Flow
-$2.11B
Cap. Flow %
-8.76%
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$157M
2
TMO icon
Thermo Fisher Scientific
TMO
+$135M
3
CRM icon
Salesforce
CRM
+$135M
4
IBM icon
IBM
IBM
+$130M
5
DELL icon
Dell
DELL
+$114M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$313M
2
AAPL icon
Apple
AAPL
+$207M
3
INTC icon
Intel
INTC
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$159M
5
CNC icon
Centene
CNC
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Technology 17.95%
3 Communication Services 13.61%
4 Consumer Discretionary 12.67%
5 Financials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEOH icon
851
Methanex
MEOH
$4.27B
$1.72M 0.01%
+51,861
New +$1.91M
DCRC
852
DELISTED
Decarbonization Plus Acquisition Corporation III Class A Common Stock
DCRC
$1.72M 0.01%
+165,853
New +$1.73M
MRTX
853
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.71M 0.01%
10,595
-231,254
-96% -$37.1M
TIXT
854
DELISTED
TELUS International
TIXT
$1.71M 0.01%
54,874
-143,669
-72% -$4.31M
CYRX icon
855
CryoPort
CYRX
$747M
$1.7M 0.01%
+26,989
New +$1.52M
CVII
856
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$1.7M 0.01%
+175,000
New +$1.71M
CMA
857
DELISTED
Comerica
CMA
$1.7M 0.01%
23,814
-37,565
-61% -$2.78M
PASG icon
858
Passage Bio
PASG
$14M
$1.68M 0.01%
6,337
-7,822
-55% -$2.42M
FPI
859
Farmland Partners
FPI
$424M
$1.67M 0.01%
+138,709
New +$1.78M
DCGOW
860
CALL
DELISTED
DocGo Inc. Warrants
DCGOW
$1.66M 0.01%
166,666
BBDC icon
861
Barings BDC
BBDC
$981M
$1.63M 0.01%
+154,556
New +$1.61M
GENI icon
862
Genius Sports
GENI
$2.1B
$1.63M 0.01%
+86,831
New +$1.72M
APR
863
DELISTED
Apria, Inc. Common Stock
APR
$1.63M 0.01%
58,028
-42,976
-43% -$1.26M
VTNR
864
DELISTED
Vertex Energy, Inc
VTNR
$1.62M 0.01%
+122,578
New +$508K
MBAC.WS
865
CALL
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$1.62M 0.01%
+166,666
New +$140K
AAQC.WS
866
CALL
DELISTED
Accelerate Acquisition Corp Warrants
AAQC.WS
$1.61M 0.01%
+166,666
New +$168K
ABBV icon
867
AbbVie
ABBV
$438B
$1.6M 0.01%
14,249
-149,318
-91% -$16.8M
BLUE
868
DELISTED
bluebird bio
BLUE
$1.6M 0.01%
3,857
+2,335
+153% +$925K
MELI icon
869
Mercado Libre
MELI
$92.6B
$1.6M 0.01%
1,026
+450
+78% +$661K
ROG icon
870
Rogers Corp
ROG
$2.3B
$1.59M 0.01%
+7,941
New +$1.52M
UFS
871
DELISTED
DOMTAR CORPORATION (New)
UFS
$1.59M 0.01%
29,023
-1,322
-4% -$64K
FSRDW
872
CALL
DELISTED
Fast Radius, Inc. Warrants
FSRDW
$1.58M 0.01%
+162,500
New +$169K
CPRI icon
873
Capri Holdings
CPRI
$1.75B
$1.58M 0.01%
27,554
-880,446
-97% -$47.9M
DD icon
874
DuPont de Nemours
DD
$19.1B
$1.57M 0.01%
16,211
-18,763
-54% -$1.88M
VLRS
875
Controladora Vuela Compania de Aviacion
VLRS
$928M
$1.57M 0.01%
81,887
+51,651
+171% +$879K

Similar funds

Marshall Wace North America's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Marshall Wace North America withdrew a net $2.11B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.

  • Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
  • Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
  • Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
  • Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
  • Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
  • Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
  • Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.